Individualized estimates of overdiagnosis in screen-detected prostate cancer.

Publication Type:

Journal Article


Journal of the National Cancer Institute, Volume 106, Issue 2, p.djt367 (2014)


2014, January 2014, Public Health Sciences Division


The chance that a prostate cancer detected by screening is overdiagnosed (ie, it would not have been detected in the absence of screening) can vary widely depending on the patient's age and tumor characteristics. The purpose of this study is to use age, Gleason score, and prostate-specific antigen (PSA) level to help inform patients with screen-detected prostate cancers about the chances their cancers were overdiagnosed.